文 献1）Masi JA, Reichert JM, Feldman L, Malins A. Clinical approval success rates for investigational cancer drugs. Clin Pharmacol Ther 2013; 94: 329-35.2）Ledford H. US cancer institute overhauls cell lines. Veteran cells to be replaced by human tumours grown in mice. Nature 2016; 530: 391.3）Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, et al. Patient derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 2014; 4: 998-1013.4）日本肝臓学会編. 肝がん白書平成27年度. 2015.5）Kageyama K, Ohara M, Saito K, Ozaki S, Terai M, Mastrangelo MJ, et al. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. J Transl Med 2017; 15: 145.6）Kageyama K, Ozaki S, Sato T. Generation of a liver orthotopic human uveal melanoma xenograft platform in immunodeficient mice. J Vis Exp 2019; (153): 10.3791/59941.7）Tanaka R, Kageyama K, Kimura K, Eguchi S, Tauchi J, Shinkawa H, et al. Establishment of a liver transplant patient-derived tumor xenograft (PDX) model using cryopreserved pancreatic ductal adenocarcinoma. Anticancer Res 2020; 40: 2637-44.8）Alkema NG, Tomar T, Duiker EW, Meersma GJ, Klip H, van der Zee AGJ, et al. Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods. Sci Rep 2015; 5: 14495.9）Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012; 47: 586-95.10） 日本肝臓学会編. 肝癌診療ガイドライン. 金原出版、 2013.11）Mashimo T, Takizawa A, Kobayashi J, Kunihiro Y, Yoshimi K, Ishida S, et al. Generation and characterization of severe combined immune deficiency rats. Cell Rep 2012; 2: 685-94.3333
元のページ ../index.html#47